Gaudium IVF's Rs 165-crore book-built issue comprises a fresh issue of shares worth Rs 90 crore and an offer for sale of Rs 75 crore by promoter and founder Dr Manika Khanna. The price band has been fixed at Rs 75-79 per share.
Private equity is growing fast in Indian healthcare. Experience from the US shows it can raise costs and debt. India must regulate investment to protect patients and care quality
The General Insurance Council has finalised standard treatment and admission guidelines for seven of the country’s most common infectious diseases following extensive consultations with healthcare providers
The changes that have been brought about in the Union Budget 2026 will have a hugely positive impact on the economy which will inevitably translate into the markets picking up, Baijayant Panda, National Vice-President of the Bharatiya Janata Party said.
Around 42.48 crore Ayushman Cards have been created till December 1 under the healthcare programme, which was launched in 2018
Revenues from international patients are growing at a healthy pace for major hospital companies
The historic FTA provides assured access for Indian contractual service suppliers across 37 sectors and independent professionals in 17 high-skill areas, while allowing intra-corporate transferees to move with their families for the first time
While public health spending has trended upward, the industry says India must bridge the gap between its current trajectory and the National Health Policy goal of 2.5% of GDP
Tax certainty, customs duty relief and healthcare infra push shape industry outlook
India must urgently shift to prevention-led, sustainably financed healthcare to manage rising NCDs, expand capacity, strengthen diagnostics and build long-term national health resilience
For Moneycontrol's Pro Panorama December 23 edition: India-New Zealand FTA matters more than critics suggest, from stabilisation to growth in India's 2026 equity market, China’s export pivot creates new risks, bond market outlook in 2026, and more
The firm remains bullish on single-specialty platforms, medical devices, digital health, and consumer healthcare, expecting India to absorb a significant share of its billion-dollar fund
The hospitals and clinics market is estimated to exceed Rs 10 lakh crore by FY29
While there are inherent risks, the growth journey remains meaningful
Consolidation, geographical expansion and investments in specialised healthcare drove deal activity
A simple, hands-on playbook to organise doctors, insurance, and emergencies from abroad—without the panic.
Bansal said misaligned incentives make the insurance claims process subpar despite India’s medical excellence, as PB Fintech expands into healthcare with its new venture PB Healthcare.
Healthcare costs have inflated in double digits post-pandemic, showing no sign of easing. Meanwhile, private equity and venture capital investments in India’s hospital landscape have touched around $15 billion since FY20. Is the changing capital structure of the healthcare business resulting in higher costs?
About 5% of Meitra’s revenue comes from overseas patients, largely from Oman. The share is expected to triple once additional capacity comes onstream, Faizal Kottikollon tells Moneycontrol
Instead of curbing doorstep delivery, India should use regulation to strengthen compliance, empower local chemists, and expand healthcare access
Star Health alone logged 13,300 complaints in FY24, over 10,000 of which were claim-related
Mutual funds raised allocations to autos for the second straight month in August, lifting sector weight to a 10-month high, aided by GST cuts and improving demand outlook. While tech made a modest comeback, private banks and healthcare saw allocations trimmed
The company has delivered a close to 4x return to investors since being recommended in MC Pro’s Discovery series
Optimistic guidance for FY26; the B2C segment should act as a key growth lever
The Indian healthcare market is experiencing robust growth and the hospital chain is uniquely placed in the paediatric segment